Amgen

Amgen study data bolster prospects of KRAS-blocking cancer drug
BioPharma Dive
Thu, 01/28/21 - 11:25 pm
Amgen
sotorasib
clinical trials
KRAS mutation
cancer
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Amgen ponies up $240M for Michigan discovery outfit's dendritic cell-based molecules for autoimmune disorders
Endpoints
Wed, 01/13/21 - 10:34 am
Amgen
autoimmune disease
Evoq Therapeutics
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Eli Lilly
Amgen
migraines
Allergan
Novartis
Biohaven
Teva Pharmaceutical
2021 Best Places to Work in Medical Sales
MedReps.com
Tue, 12/22/20 - 10:58 am
devices
drug reps
Syneos Health
Teleflex
Avion Pharmaceuticals
Acella
Conmed
Acumed
Lundbeck
Amgen
Biogen
Spark Therapeutics
Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III
BioSpace
Tue, 12/22/20 - 10:47 am
Amgen
AstraZeneca
asthma
clinical trials
tezepelumab
Amgen and Novartis tap TV host to jump-start migraine conversations—and fuel understanding
Fierce Pharma
Wed, 12/16/20 - 10:40 pm
Aimovig
Amgen
Novartis
migraines
celebrity endorsements
Could Amgen's Xgeva boost immunotherapy in breast cancer?
Fierce Biotech
Mon, 12/14/20 - 10:37 am
Amgen
Xgeva
breast cancer
Vigil Neuroscience launches with a $50M Series A and two former Amgen neuroscience candidates
Endpoints
Tue, 12/8/20 - 10:44 am
Vigil Neuroscience
funding
Amgen
Neurosciences
Amgen plans 2020 filing for FDA approval of KRAS drug sotorasib
Fierce Biotech
Tue, 12/8/20 - 10:43 am
Amgen
FDA
sotorasib
KRAS
Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study
Pharmaceutical Business Review
Wed, 12/2/20 - 10:24 am
COVID-19
pandemic
clinical trials
Takeda
Amgen
UCB
COVID R&D Alliance
Amgen severs 14-year Cytokinetics partnership, bailing on omecamtiv after mixed PhIII results
Endpoints
Mon, 11/23/20 - 10:16 pm
Amgen
Cytokinetics
omecamtiv
clinical trials
AHA 2020 – look out for the omecamtiv fault lines
EP Vantage
Mon, 11/16/20 - 10:13 am
AHA
Omecamtiv Mecarbil
Amgen
Cytokinetics
heart failure
Amgen, AstraZeneca's tezepelumab hits goal in asthma phase 3
Fierce Pharma
Tue, 11/10/20 - 10:41 am
Amgen
AstraZeneca
tezepelumab
asthma
severe asthma
clinical trials
Bristol Myers' psoriasis drug beats Amgen rival in phase 3
Fierce Biotech
Tue, 11/3/20 - 10:49 am
Bristol-Myers Squibb
deucravacitinib
Amgen
Otezla
clinial trials
plaque psoriasis
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Motley Fool
Thu, 10/29/20 - 12:01 pm
Amgen
earnings
Otezla
Amgen Reports Stronger-Than-Expected Q3 Earnings; Revenue Gains 12%
TheStreet.com
Wed, 10/28/20 - 11:19 pm
Amgen
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Sun, 10/25/20 - 11:30 pm
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Amgen and Cytokinetics claim heart drug success, but results widely disappoint
BioPharma Dive
Thu, 10/8/20 - 11:19 pm
Amgen
Cytokinetics
Servier
clinical trials
Omecamtiv Mecarbil
cardiovascular disease
Amgen teases 'promising' phase 2 data for closely watched KRAS prospect
Fierce Biotech
Tue, 10/6/20 - 10:26 am
Amgen
clinical trials
non-small cell lung cancer
KRAS
sotorasib

Pages